What is Prostate Cancer TMPRSS2-ERG Fusion Gene Detection Kit?

Prostate Cancer is a anatomy of blight that develops in the prostate, a gland in the macho changeable system. A lot of prostate cancers are apathetic growing; however, there are cases of advancing prostate cancers. The blight beef may clarify (spread) from the prostate to added locations of the body, decidedly the basic and lymph nodes. Prostate blight may could cause pain, adversity in urinating, problems during animal intercourse, or arrect dysfunction. Added affection can potentially advance during after stages of the disease.
Rates of apprehension of prostate cancers alter broadly beyond the world, with South and East Asia audition beneath frequently than in Europe, and abnormally the United States. Prostate blight tends to advance in men over the age of fifty and although it is one of the a lot of accustomed types of blight in men, abounding never accept symptoms, abide no therapy, and eventually die of added causes. This is because blight of the prostate is, in a lot of cases, slow-growing, symptom-free, and back men with the action are earlier they generally die of causes different to the prostate cancer, such as heart/circulatory disease, pneumonia, added alone cancers, or old age. On the added hand, the added advancing prostate cancers annual for added cancer-related deaths a part of men in the United States than any added blight except lung cancer. About two-thirds of cases are apathetic growing, the added third added advancing and fast developing.
Prostate Cancer screening is an attack to acquisition buried cancers, and may advance to added specific aftereffect tests such as a biopsy, with corpuscle samples taken for afterpiece study. Options cover the agenda abdominal assay (DRE) and the prostate-specific antigen (PSA) claret test. Such screening is arguable and, in some people, may advance to unnecessary, even harmful, consequences. Routine screening with either a DRE or PSA is not accurate by the affirmation as there is no bloodshed account from screening. The United States Preventive Services Task Force (USPSTF) recommended adjoin the PSA analysis for prostate blight screening in advantageous men behindhand of age. This USPSTF recommendation, appear in October 2011, is based on "review of evidence" studies absolute that "Prostate-specific antigen–based screening after-effects in baby or no abridgement in prostate cancer–specific bloodshed and is associated with harms accompanying to consecutive appraisal and treatments, some of which may be unnecessary."
More about: Prostate Cancer TMPRSS2-ERG Fusion Gene Detection Kit sale
Read more: chemical reagent

Where to get Prostate Cancer TMPRSS2-ERG Fusion Gene Detection Kit?

Transmembrane protease, serine 2 is an enzyme that in humans is encoded by the TMPRSS2 gene.
This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are known to be involved in many physiological and pathological processes. This gene was demonstrated to be up-regulated by androgenic hormones in prostate cancer cells and down-regulated in androgen-independent prostate cancer tissue. The protease domain of this protein is thought to be cleaved and secreted into cell media after autocleavage. The biological function of this gene is unknown.
TMPRSS2 protein's function in prostate carcinogenesis relies on overexpression of ETS transcription factors, such as ERG and ETV1 through gene fusion. TMPRSS2-ERG fusion gene is the most frequent, present in 40% - 80% of prostate cancers in humans. ERG overexpression contributes to development of androgen-independence in prostate cancer through disruption of androgen receptor signaling.
TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we explored the role of TMPRSS2-ERG gene fusion product using in vitro and in vivo model systems. Transgenic mice expressing the ERG gene fusion product under androgen-regulation develop mouse prostatic intraepithelial neoplasia (PIN), a precursor lesion of prostate cancer. Introduction of the ERG gene fusion product into primary or immortalized benign prostate epithelial cells induced an invasion-associated transcriptional program but did not increase cellular proliferation or anchorage-independent growth.
More about: Prostate Cancer TMPRSS2-ERG Fusion Gene Detection Kit sale
Read more: reagents